Attacking MALT1 for ABC-DLBCL therapy

被引：0
|
作者：
Krappmann, Daniel [1 ]
机构：
[1] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Cellular Signal Integrat, Inst Mol Toxicol & Pharmacol, Neuherberg, Germany
来源：
ONCOTARGET | 2012年 / 3卷 / 12期
关键词：
PROTEASE;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1489 / 1490
页数：2
相关论文
共 50 条
  • [41] Potent small molecule compounds that selectively inhibit proliferation of ABC-DLBCL cell lines
    Satyam, Leena Khare
    Chikkanna, Dinesh
    Khairnar, Vinayak
    Pothuganti, Manoj
    Panigrahi, Sunil
    Lakshminarasimhan, Anirudha
    Rao, Narasimha
    Balasubramanian, Wesley
    Patil, Sandeep
    Gopinath, Sreevalsam
    Upendra, Gunta
    Nagaraj, Jwala
    Aithal, Kiran
    Ahuja, Vijay
    Giri, Sanjeev
    Pandit, Chetan
    Ramachandra, Murali
    CANCER RESEARCH, 2017, 77
  • [42] TPL2, a New Prognostic Factor and a Potential Therapeutic Target in ABC-DLBCL
    Yoshifuji, Kota
    Motomura, Yotaro
    Saito, Makiko
    Nogami, Ayako
    Kawade, Genji
    Watabe, Shiori
    Yamamoto, Kouhei
    Mori, Takehiko
    Nagao, Toshikage
    BLOOD, 2022, 140 : 5915 - 5916
  • [43] CARD11 is critical for in vitro and in vivo growth of ABC-DLBCL cells.
    Murtie, Joshua C.
    Zhu, Julia
    Wang, Hongyun
    Ospina, Beatriz
    Cindhuchao, May
    Hoffman, Dietmar
    Greco, Rita
    Dorsch, Marion
    Adrian, Francisco
    CANCER RESEARCH, 2013, 73 (08)
  • [44] IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL
    Li, Han-Bing
    Wang, Di
    Zhang, Yue
    Shen, Di
    Che, Yi-Qun
    JOURNAL OF ONCOLOGY, 2023, 2023
  • [45] Biomarker Predictive Ibrutinib Response Using Profiled ABC-DLBCL Patient Derived Xenografts
    Wu, Ran
    Guo, Sheng
    Cai, Jie
    Huang, Xuesong
    Yang, Jie
    Wery, Jean-Pierre
    Li, Henry Qi-xiang
    BLOOD, 2015, 126 (23)
  • [46] A New "Brew" of MALT1 Inhibitors
    Young, Ryan M.
    Staudt, Louis M.
    CANCER CELL, 2012, 22 (06) : 706 - 707
  • [47] MALT1 Rearrangements in BAL Fluid
    Borie, Raphael
    Wislez, Marie
    Fleury-Feith, Jocelyne
    Delfau-Larue, Marie-Helene
    Cadranel, Jacques
    CHEST, 2012, 142 (01) : 262 - 262
  • [48] MALT1 in glioblastoma: the Flowers of Evil
    Maghe, Clement
    Jacobs, Kathryn A.
    Bidere, Nicolas
    Gavard, Julie
    M S-MEDECINE SCIENCES, 2020, 36 (05): : 452 - 454
  • [49] Malt1 deficient mice develop osteoporosis independent of osteoclast-intrinsic effects of Malt1 deficiency
    Monajemi, Mahdis
    Fisk, Shera
    Pang, Yvonne C. F.
    Leung, Jessica
    Menzies, Susan C.
    Ben-Othman, Rym
    Cai, Bing
    Kollmann, Tobias R.
    Rozmus, Jacob
    Sly, Laura M.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2019, 106 (04) : 863 - 877
  • [50] ARQ 531, A REVERSIBLE BTK INHIBITOR, DEMONSTRATES POTENT ANTI-TUMOR ACTIVITY IN ABC-DLBCL AND GCB-DLBCL
    Eathiraj, S.
    Yu, Y.
    Hall, T.
    Schwartz, B.
    Woyach, J. A.
    Reiff, S.
    Abbadessa, G.
    HAEMATOLOGICA, 2017, 102 : 574 - 574
12345